alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 16.117 Documentation of informed consent. ( a ) Except as provided in paragraph (c) of this section, informed consent shall be documented by the use of a written informed consent form approved by the IRB and signed (including in an electronic format) by the subject or the subject's legally authorized representative. A written copy shall be given to the person signing the informed consent form.
( b ) Except as provided in paragraph (c) of this section, the informed consent form may be either of the following: ( 1 ) A written informed consent form that meets the requirements of § 16.116. The investigator shall give either the subject or the subject's legally authorized representative adequate opportunity to read the informed consent form before it is signed; alternatively, this form may be read to the subject or the subject's legally authorized representative.
( 2 ) A short form written informed consent form stating that the elements of informed consent required by § 16.116 have been presented orally to the subject or the subject's legally authorized representative, and that the key information required by § 16.116(a)(5)(i) was presented first to the subject, before other information, if any, was provided. The IRB shall approve a written summary of what is to be said to the subject or the legally authorized representative. When this method is used, there shall be a witness to the oral presentation. Only the short form itself is to be signed by the subject or the subject's legally authorized representative. However, the witness shall sign both the short form and a copy of the summary, and the person actually obtaining consent shall sign a copy of the summary. A copy of the summary shall be given to the subject or the subject's legally authorized representative, in addition to a copy of the short form.
( c ) ( 1 ) An IRB may waive the requirement for the investigator to obtain a signed informed consent form for some or all subjects if it finds any of the following: ( i ) That the only record linking the subject and the research would be the informed consent form and the principal risk would be potential harm resulting from a breach of confidentiality. Each subject (or legally authorized representative) will be asked whether the subject wants documentation linking the subject with the research, and the subject's wishes will govern;
( ii ) That the research presents no more than minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of the research context; or
( iii ) If the subjects or legally authorized representatives are members of a distinct cultural group or community in which signing forms is not the norm, that the research presents no more than minimal risk of harm to subjects and provided there is an appropriate alternative mechanism for documenting that informed consent was obtained.
( 2 ) In cases in which the documentation requirement is waived, the IRB may require the investigator to provide subjects or legally authorized representatives with a written statement regarding the research.
(Approved by the Office of Management and Budget under Control Number 0990-0260)
<TABLE> <S> <C>

      <ARTICLE> 5
      <LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THE  REGISTRANT'S QUARTERLY FINANCIAL STATEMENTS AND IS QUALIFIED IN
ITS  ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
      </LEGEND>
             
      <S>                                                <C>
      <PERIOD-TYPE>                                    3-MOS
      <FISCAL-YEAR-END>                          DEC-27-1998
      <PERIOD-END>                               SEP-30-1998
      <CASH>                                          80,217
      <SECURITIES>                                         0
      <RECEIVABLES>                                   42,665
      <ALLOWANCES>                                    85,000
      <INVENTORY>                                          0
      <CURRENT-ASSETS>                               252,715
      <PP&E>                                         130,400
      <DEPRECIATION>                                  12,079
      <TOTAL-ASSETS>                               1,195,740
      <CURRENT-LIABILITIES>                          332,387
      <BONDS>                                              0
      <PREFERRED-MANDATORY>                                0
      <PREFERRED>                                          0
      <COMMON>                                     4,456,457
      <OTHER-SE>                                 (4,586,916)
      <TOTAL-LIABILITY-AND-EQUITY>                 1,195,740
      <SALES>                                              0
      <TOTAL-REVENUES>                               103,427
      <CGS>                                               11
      <TOTAL-COSTS>                                  114,944
      <OTHER-EXPENSES>                              (15,028)
      <LOSS-PROVISION>                                     0
      <INTEREST-EXPENSE>                                   0
      <INCOME-PRETAX>                                  3,506
      <INCOME-TAX>                                         0
      <INCOME-CONTINUING>                              3,506
      <DISCONTINUED>                                       0
      <EXTRAORDINARY>                                      0
      <CHANGES>                                            0
      <NET-INCOME>                                     3,506
      <EPS-PRIMARY>                                     .000
      <EPS-DILUTED>                                     .000


              
      
</TABLE>
Exhibit 31

Certifications

I, Richard Simpson, certify that:

1.I have reviewed this report on Form 10-K and all reports on Form 10-D required to be filed in respect of the period covered by this report on Form 10-K of Citigroup Commercial Mortgage Trust 2020-GC46 (the “Exchange Act periodic reports”);

2.Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, all of the distribution, servicing and other information required to be provided under Form 10-D for the period covered by this report is included in the Exchange Act periodic reports;

4.Based on my knowledge and the servicer compliance statement(s) required in this report under Item 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicers have fulfilled their obligations under the servicing agreements in all material respects; and

5.All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their related attestation reports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwise disclosed in this report.  Any material instances of noncompliance described in such reports have been disclosed in this report on Form 10-K.

In giving the certifications above, I have reasonably relied on information provided to me by the following unaffiliated parties: Midland Loan Services, a Division of PNC Bank, National Association; CWCapital Asset Management LLC; Park Bridge Lender Services LLC; U.S. Bank National Association; KeyBank National Association; LNR Partners, LLC; Situs Holdings LLC; Pentalpha Surveillance LLC; Wells Fargo Bank, National Association; Computershare Trust Company, National Association; CoreLogic Solutions, LLC; and Wilmington Trust, National Association.

Date:March 30, 2022

|  | /s/ Richard Simpson ___________________Richard SimpsonPresident, Citigroup Commercial Mortgage Securities Inc.(senior officer in charge of securitization of the depositor) |
|--|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

CGCMT 2020-GC46 Certifications
| Dated:   May 17, 2010                    | /s/ Raul S. McQuivey                  |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|--------|
|                                                                                                                                                   | Raul S. McQuivey                      |   |
|                                                                                                                                                   | President and Chief Executive Officer |   |
|                                                                                                                                                   | (Principal Executive Officer)         |   |

| Dated:   May 17, 2010                    | /s/ Sidney C. Hooper           |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------|--------|
|                                                                                                                                                   | Sidney C. Hooper               |   |
|                                                                                                                                                   | Chief Financial Officer        |   |
|                                                                                                                                                   | (Principal Accounting Officer) |   |
#### Frederick Banzhaf, Respondent, *v.*Bernhard J. Ludwig et al., Appellants.

Appeal from a judgment in favor of plaintiff, entered upon a verdict, and from an order denying a motion for a new trial.

Wager *&*Acker, for appellants.

Julius Heiderman, for respondent.

Conlan, J.

This is an appeal from a judgment of the Trial Term, entered upon the verdict of a jury, and from an order denying a motion for a new trial.

The action is for damages for personal injury. The plaintiff was a carpenter in the defendants’ employ, had been such for two years prior to the accident, and was under the orders of one Beck, who was the foreman, with respect to the work being done upon the defendants’ premises.

A temporary scaffold of planks erected in a show-window of defendants’ place, fell on the 10th day of April, 1895, and the plaintiff, who was working upon the scaffold, fell and was injured.

There is some dispute as to when this scaffold was erected, the plaintiff asserting that it was erected on the 9th. of April, the day previous to the accident, while the witness Beck, for the defendants, says it was erected on the morning of the 10th of April.

The plaintiff is fully corroborated in his testimony upon this point, and we cannot say that there was not a fair preponderance of evidence in his favor on this, as on all the other matters, which were submitted to the jury.

It does not appear that the plaintiff participated in any way in the erection of this scaffold, and he says that the foreman directed him to go up on it the morning of the 10th of April,, declaring it to be sufficient for the purpose for which it was erected.

*822It is in evidence also that another workman called the attention of Beck to the scaffold, and that it required some bracing, and that Beck replied that it was all right.

Thus it appears that the whole case is fairly submitted to the jury, and it is not in the province of a court of appeal to interfere with the deliberations and findings of the jury, unless it distinctly appeared that manifest error or injustice had been committed.

In the case at bar we do not find any such objections or exception presented by the record, and, for the reasons stated, the judgment should be affirmed.

Judgment and order appealed from affirmed, with costs.

McCarthy, J., concurs.

Judgment and order affirmed, with costs.
#### § 360.31 Withdrawal of claims.

Any claimant may withdraw its claim for any royalty year as of right by filing a Notice of Withdrawal of Claim(s). If a single claimant filed a Petition to Participate in a proceeding, withdrawal of the claim shall serve to dismiss the Petition to Participate. If the claimant withdrawing a claim was included on the Petition to Participate of another entity, withdrawal of the claim shall not affect the Petition to Participate as to other claims listed thereon. All Notices of Withdrawal of Claim(s) must be filed online through eCRB.

[82 FR 27018, June 13, 2017, as amended at 85 FR 37753, June 24, 2020]
§ 86.17 Nondiscrimination. ( a ) Attention is called to the requirements of title VI of the Civil Rights Act of 1964 (78 Stat. 252, 42 U.S.C. 2000d *et seq.*) and in particular section 601 of such Act which provides that no person in the United States shall on the grounds of race, color, or national origin be excluded from participation in, be denied the benefits of, or be subjected to, discrimination under any program or activity receiving Federal financial assistance. A regulation implementing such title VI, which applies to grants made under this subpart, has been issued by the Secretary of Health and Human Services with the approval of the President (45 CFR part 80).
( b ) Attention is called to the requirements of title IX of the Education Amendments of 1972 (86 Stat. 373, 20 U.S.C. 1681 *et seq.*) and in particular to section 901 of such Act which provides that no person in the United States shall, on the basis of sex, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any education program or activity receiving Federal financial assistance.
( c ) Attention is called to the requirements of section 504 of the Rehabilitation Act of 1973, as amended, which provides that no otherwise qualified handicapped individual in the United States shall, solely by reason of his handicap, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any program or activity receiving Federal financial assistance.
Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 2 is placed in the separate grouping of parts pertaining to trademarks regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 6 is placed in the separate grouping of parts pertaining to trademarks regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 7 is placed in the separate grouping of parts pertaining to trademarks regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 1 is placed in the separate grouping of parts pertaining to patents regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 3 pertaining to both patents and trademarks is placed in the grouping pertaining to patents regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 4 is placed in the separate grouping of parts pertaining to patents regulations.

Editorial Note on Subchapter A of Chapter I
Editorial Note: Part 5 is placed in the separate grouping of parts pertaining to patents regulations.

§ 41.154 Form of evidence. ( a ) Evidence consists of affidavits, transcripts of depositions, documents, and things. All evidence must be submitted in the form of an exhibit.
( b ) *Translation required.* When a party relies on a document or is required to produce a document in a language other than English, a translation of the document into English and an affidavit attesting to the accuracy of the translation must be filed with the document.
( c ) An exhibit must conform with the requirements for papers in § 41.106 of this subpart and the requirements of this paragraph. ( 1 ) Each exhibit must have an exhibit label with a unique number in a range assigned by the Board, the names of the parties, and the proceeding number in the following format: JONES EXHIBIT 2001 Jones v. Smith Contested Case 104,999
( 2 ) When the exhibit is a paper: ( i ) Each page must be uniquely numbered in sequence, and
( ii ) The exhibit label must be affixed to the lower right corner of the first page of the exhibit without obscuring information on the first page or, if obscuring is unavoidable, affixed to a duplicate first page.
( d ) *Exhibit list.* Each party must maintain an exhibit list with the exhibit number and a brief description of each exhibit. If the exhibit is not filed, the exhibit list should note that fact. The Board may require the filing of a current exhibit list prior to acting on a motion.
[69 FR 50003, Aug. 12, 2004, as amended at 69 FR 58260, Sept. 30, 2004]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

          - [Transmittal Nos. 09-47]

# AGENCY:

Department of Defense, Defense Security Cooperation Agency.

# ACTION:

Notice.

# SUMMARY:

The Department of Defense is publishing the unclassified text of a section 36(b)(1) arms sales notification. This is published to fulfill the requirements of section 155 of Public Law 104-164 dated 21 July 1996.

# FOR FURTHER INFORMATION CONTACT:

Ms. B. English, DSCA/DBO/CFM, (703) 601-3740.

The following is a copy of a letter to the Speaker of the House of Representatives, Transmittals 09-47 with attached transmittal, and policy justification.

Dated: September 15, 2009.

Patricia L. Toppings,

OSD Federal Register Liaison Officer, Department of Defense.

      ( print page 48924)          ( print page 48925)          ( print page 48926)          ( print page 48927)    

BILLING CODE 5001-06-P

[FR Doc. E9-22948 Filed 9-24-09; 8:45 am]

BILLING CODE 5001-06-C
**
**Exhibit 32.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

**PURSUANT TO**

**SECTION 906OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)**

In connection with the Annual Report on Form10-K for the year ended December 31, 2021 (the “Report”) of Stone Point Credit Corporation (the “Company”), as filed with the Securities and Exchange Commission on the date hereof, I,Gene Basov, the Principal Financial Officer of the Company, hereby certify, to the best of my knowledge, that: 

 
 (1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Actof 1934, as amended; and 

 
 (2)
The information contained in the Report fairly presents, in all material respects, the financial condition andresults of operations of the Company. 

 

/s/ Gene Basov
**Name: Gene Basov****Date: March 30, 2022****
I 

110TH CONGRESS 

1ST SESSION H. R. 2249 

To amend title 28, United States Code, to prevent administrative action 

with respect to, and the filing of, certain tort claims against the United 

States. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 9, 2007 

Mr. MCCAUL of Texas (for himself, Mr. BRADY of Texas, and Mr. POE) introduced the following bill; which was referred to the Committee on the Judiciary 

A BILL 

To amend title 28, United States Code, to prevent administrative action with respect to, and the filing of, certain 

tort claims against the United States. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Federal Tort Claim 

5 Reform Act of 2007’’. 

6 SEC. 2. EXCEPTION TO TORT CLAIMS AUTHORITY. 

7 Section 2680 of title 28, United States Code, is 

8 amended by adding at the end the following: 


pwalker on PROD1PC71 with BILLS
2 

•HR 2249 IH

1 ‘‘(o) Any claim, based on an act or omission by 

2 an employee of the Government relating to criminal 

3 conduct, that is made by a person who engaged in 

4 that conduct, except to the extent the act or omis5 sion consists of the purposeful infliction of serious 

6 bodily injury and the damages sought by the claim7 ant are actual losses resulting from the act or omis8 sion. For the purposes of this paragraph the term 

9 ‘actual losses’ means medical expenses, lost wages, 

10 property damage, and other tangible loss, but may 

11 not exceed $250,000.’’. 

Æ 


pwalker on PROD1PC71 with BILLS
Summary of New Restricted Stock Bonus Grants to Executive Officers



 Exhibit 10.2 
  
 New Restricted Stock Bonus Grants to Executive Officers Under The Openwave Systems Inc 2001 Stock Compensation Plan 
  
 The following grants were made using the form of Restricted Stock Bonus agreement filed as
Exhibit 10.2 to the Company’s Annual Report on Form 10-K filed on September 30, 2002 
  

	Participant	  	Grant Date	  	 Restricted
 Shares
	  	Vesting Schedule
	

	 David Hose
	  	10/27/2003	  	16,666	  	1/36 of the shares monthly beginning on 11/27/03
	 Joshua Pace
	  	10/27/2003	  	  4,166	  	1/36 of the shares monthly beginning on 11/27/03
	 Steve Peters
	  	10/27/2003	  	16,666	  	1/36 of the shares monthly beginning on 11/27/03
	 Jon Shantz
	  	10/27/2003	  	16,666	  	1/36 of the shares monthly beginning on 11/27/03
	 Allen Snyder
	  	10/27/2003	  	16,666	  	1/36 of the shares monthly beginning on 11/27/03
§ 223.3 Class action opt-out procedures. ( a ) *Opt-out or dismissal procedures.* Any party to an active proceeding before the Copyright Claims Board (“Board”) who receives notice of a pending or putative class action, arising out of the same transaction or occurrence as the proceeding before the Board, in which the party is a class member, shall either opt out of the class action or seek written dismissal of the proceeding before Board within 14 days of receiving notice of the pending class action. If a party seeks written dismissal of the proceeding before the Board, upon notice to all claimants and counterclaimants, the Board shall dismiss the proceeding without prejudice.
( b ) *Filing requirement.* A copy of the notice indicating a party's intent to opt out of a class action proceeding must be filed with the Board within 14 days after the filing of the notice with the court.
( c ) *Timing.* The time periods provided in paragraphs (a) and (b) of this section may be extended by the Board for good cause shown.
( d ) *Failure to notify Board.* If a party fails to make a timely election under paragraph (a) of this section, the Board is authorized to take corrective action as it deems necessary, which may include dismissal of a pending claim before the Board with or without prejudice, notifying the class action court of any final determination by the Board, or vacating a final determination of the Board. The Board may, in its discretion, direct a party to show cause why action under paragraph (a) of this section was not taken.